Data Strategy Consulting

A smart data strategy is essential to innovation, compliance, and performance. It is fundamental to the successful implementation of AI and new technologies into Life Science companies.

Business professionals working with charts graphs at a table

Why Do You Need a Data Strategy?

A robust data strategy is crucial, as it aligns data with business objectives, ensures clean and contextualized data, and establishes comprehensive data standards and governance.

Data Strategy Benefits

Innovation icon

Innovation and Efficiency

A streamlined operation built on the foundation of optimized data collection, storage, and utilization is a fundamental requirement for improving operational performance and...

Read More

Innovation and Efficiency

A streamlined operation built on the foundation of optimized data collection, storage, and utilization is a fundamental requirement for improving operational performance and driving innovation.

Read Less
Regulatory Sciences icon

Regulatory Compliance

Since the pharmaceutical, agrochemical, and food science industries are heavily regulated, it is imperative that an organisation's data strategy ensures that data complies with...

Read More

Regulatory Compliance

Since the pharmaceutical, agrochemical, and food science industries are heavily regulated, it is imperative that an organisation's data strategy ensures that data complies with regulations. Strategy compliance will reduce the risk of data integrity issues.

Read Less
Decentralized Clinical Trials icon

Improved Patient Outcomes

A well-defined data strategy that aligns with the business's goals and objectives will lead to improved decision-making and, ultimately, better research, which in turn leads...

Read More

Improved Patient Outcomes

A well-defined data strategy that aligns with the business's goals and objectives will lead to improved decision-making and, ultimately, better research, which in turn leads to better patient outcomes.

Read Less
Clinical technology services icon

Competitive Advantage

Data-driven decision-making will enable your organization to develop a clear advantage in the market. Data enables you to make decisions faster and with more confidence.

Competitive Advantage

Data-driven decision-making will enable your organization to develop a clear advantage in the market. Data enables you to make decisions faster and with more confidence.

Read Less
Service icon

Cost Reduction

Efficient data management with a well-defined data governance and data standards framework will reduce cycle time and inefficiencies associated with inconsistent or duplicated records....

Read More

Cost Reduction

Efficient data management with a well-defined data governance and data standards framework will reduce cycle time and inefficiencies associated with inconsistent or duplicated records. This will, in turn, lead to a reduction in baseline costs due to resource rationalization and the need for rework and error handling.

Read Less
Webinar icon

Enhanced Collaboration

Data strategies ensure better collaboration between departments and functions in your organization. This is achieved through the robust characterization of data use cases that...

Read More

Enhanced Collaboration

Data strategies ensure better collaboration between departments and functions in your organization. This is achieved through the robust characterization of data use cases that prioritizing collaboration and multi-group impact.

Read Less

How Can We Help With Your Data Strategy?

LRQA Certified ISO 9001 Logo

Our Data Strategy Consulting service offers a comprehensive approach to enhancing how your organization uses its data, tailored to your business goals and operating model. Our consultants have lab experience and scientific domain knowledge from R&D to clinical operations so we understand your challenges and can help you illustrate what success looks like.

We are also experienced in helping companies implement the FAIR principles in a way that is appropriate for your organizational policies, goals, and technical capabilities. This process is grounded in our extensive industry experience with similar data-centric initiatives as well as cross-industry collaborations and consortia (Allotrope, Pistoia, IUPAC, etc.).

Professional workers collaborating in an office

Our Data Strategy Process

Submissions icon

Data Maturity Assessment

Assessing your current data maturity level against industry-wide standard definitions enables us to work with you to develop a roadmap that will move your business up the data maturity scale. By revisiting this, your progress against the data strategy can be effectively monitored.

Expert Witness icon

Data Strategy, Governance, and Standards

By working with you to build the strong foundations of a data strategy, governance and standards, we enable you to make more effective use of your data. A comprehensive data strategy ensures alignment with your business goals and objectives. A well-defined data governance framework enhances your business data management capabilities. Clear data standards provide confidence in data quality and support your informed, data-driven decision making.

Adverse event intake icon

Use Cases

Use cases are essential considerations in defining the practical application of data, ensuring that insights align with your business objectives and drive measurable outcomes. By working with you to identify and implement clear use cases, your organization can prioritize data initiatives, optimize resource allocation, and enhance decision-making effectiveness.

Pin leading to another pin icon

What's Next

No matter where you are in your data strategy journey, we can help establish the essential foundations that lead to a clear roadmap and action plan for confident, data-driven decision-making. We can also provide comprehensive support for new implementations, including change management, communication planning, and training. This ensures you can effectively start to leverage AI and ML to drive meaningful value for your business. 

Expert Data Strategy Consulting Services

Our data strategy consulting services align your data with business goals—empowering innovation, ensuring compliance, and enabling confident, data-driven decisions.

Our Data Strategy Consultants & Experts

  • Andrew Newell Bio Photo

    Andrew Newell

    Team Lead Business Consultant

    View Bio

  • Joost Van Kempen Bio Photo

    Joost Van Kempen

    Business Consultant

    View Bio

  • Pete Bament Bio Photo

    Pete Bament

    Business Consultant

    View Bio

  • Dana Vanderwall Bio Photo

    Dana Vanderwall

    Senior Director, Digital Transformation

    View Bio

  • Michael Burns Bio Photo

    Michael Burns

    Business Consultant

    View Bio

  • Kirsty Payne Bio Photo

    Kirsty Payne

    Business Consultant

    View Bio

Andy is an experienced IT and operational leader with over 30 years of experience in the sector. With roles in operations, business technology, and IT, he has a broad understanding of digital transformation through the lenses of technology delivery and users at all levels. He has extensive experience as a business partner to operational leaders and IT technical leads.

Joost is an experienced leader in providing strategies that help organizations improve their science through better utilization of technology and data. He has been instrumental in setting up and implementing data and digitization strategies in a diverse set of international settings across both industry and academia.

Pete is an experienced data leader with over 22 years of experience working across the pharmaceutical product lifecycle, from R&D to manufacturing. He has developed a broad knowledge base through personal experience and by working closely with partners in Quality, Technical, Production, Logistics, Finance, Clinical, Data, and IT functions.

Dana Vanderwall is an innovative leader in scientific solutions for drug discovery and digital transformation, with over 25 years of experience in pharmaceutical and biopharma R&D. He has experience in biochemistry, structural biology, computational chemistry, cheminformatics, IT, and data strategy in pharmaceutical R&D, as well as product management for enterprise informatics software. Dana has extensive experience providing an interface between IT and senior R&D leadership, responsible for the planning and delivery of informatics platforms, services, and tools in alignment with scientific goals and strategy. He has also led the strategy development and implementation of an R&D-wide metadata layer.

Michael Burns has over 20 years of experience providing technical and business solutions to the pharmaceutical and biopharma R&D sector. He has experience in the Information Technology domain supporting, delivering, and managing IT solutions. He has also worked extensively as a consultant, delivering scientific software solutions, including Electronic Laboratory Notebooks, Data Management, Bioinformatics, and streamlining scientific workflows.

Mike has a proven track record of fostering understanding and collaboration across diverse groups of stakeholders.

Kirsty is a skilled technical project manager with over 20 years of experience in data management, software implementation, and data integrity management within regulatory environments, across the CRO and pharmaceutical sectors. She has a proven track record of driving process improvements, delivering training, and leading continuous enhancement initiatives.

News & Insights

Modernizing Case Management for Global Compliance

June 8, 2026

Modernizing Case Management for Global Compliance

Discover how E2B (R3) is modernizing pharmacovigilance case management, improving compliance, and streamlining adverse event reporting across global regulatory authorities.

Why Medical Information Is Critical to Adverse Event Reporting

June 1, 2026

Why Medical Information Is Critical to Adverse Event Reporting

Discover the vital role of Medical Information in adverse event reporting and how it enhances patient safety and regulatory compliance in the pharmaceutical industry.

Rethinking the Role of the Medical Information Contact Center: An Untapped Resource for Medical Writing

May 25, 2026

Rethinking the Role of the Medical Information Contact Center: An Untapped Resou...

Explore how Medical Information contact centers can enhance medical writing by leveraging their expertise and adaptability in response to evolving demands.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

May 20, 2026

Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed - Pro...

When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...

Case Study Reestablishing FDA Alignment After a CMC Disruption: A Strategic Path to BLA Approval

May 20, 2026

From Clinical Hold to Approval: Overcoming CMC Challenges to Achieve BLA Approva...

A critical CMC change during Phase 3 development led to a partial clinical hold, putting timelines, regulatory alignment, and commercial readiness at risk. In this case study, learn how we partnered...

Case Study Response to Regulatory Request with Subsequent Full Signal Assessment

May 15, 2026

Response to Regulatory Request with Subsequent Full Signal Assessment - ProPharm...

Responding to urgent regulatory safety requests requires balancing speed, scientific rigor, and global compliance. When concerns emerged regarding a potential neurotoxicity signal, the client needed...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

News & Insights

Modernizing Case Management for Global Compliance

June 8, 2026

Modernizing Case Management for Global Compliance

Discover how E2B (R3) is modernizing pharmacovigilance case management, improving compliance, and streamlining adverse event reporting across global regulatory authorities.

Why Medical Information Is Critical to Adverse Event Reporting

June 1, 2026

Why Medical Information Is Critical to Adverse Event Reporting

Discover the vital role of Medical Information in adverse event reporting and how it enhances patient safety and regulatory compliance in the pharmaceutical industry.

Rethinking the Role of the Medical Information Contact Center: An Untapped Resource for Medical Writing

May 25, 2026

Rethinking the Role of the Medical Information Contact Center: An Untapped Resou...

Explore how Medical Information contact centers can enhance medical writing by leveraging their expertise and adaptability in response to evolving demands.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

May 20, 2026

Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed - Pro...

When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...

Case Study Reestablishing FDA Alignment After a CMC Disruption: A Strategic Path to BLA Approval

May 20, 2026

From Clinical Hold to Approval: Overcoming CMC Challenges to Achieve BLA Approva...

A critical CMC change during Phase 3 development led to a partial clinical hold, putting timelines, regulatory alignment, and commercial readiness at risk. In this case study, learn how we partnered...

Case Study Response to Regulatory Request with Subsequent Full Signal Assessment

May 15, 2026

Response to Regulatory Request with Subsequent Full Signal Assessment - ProPharm...

Responding to urgent regulatory safety requests requires balancing speed, scientific rigor, and global compliance. When concerns emerged regarding a potential neurotoxicity signal, the client needed...

Previous Resource Arrow Next Resource Arrow
Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Previous Webinar Arrow Next Webinar Arrow